Home > Boards > US Listed > Biotechs > PharmaCyte Biotech Inc. (PMCB)

That is a fair argument. I have no

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
mwebb1514 Member Profile
 
Followed By 9
Posts 581
Boards Moderated 0
Alias Born 04/26/13
160x600 placeholder
H.C. Wainwright Keeps a Hold Rating on PharmaCyte Biotech (PMCB) TipRanks - 11/30/2021 12:05:16 PM
PharmaCyte Biotech Launches Malignant Ascites Program with Commencement of Pivotal Preclinical Study Business Wire - 11/30/2021 1:05:00 AM
PharmaCyte Biotech Announces Cell Encapsulation Technology Material Does Not Cause Skin Irritation Business Wire - 11/12/2021 9:00:00 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 11/8/2021 6:01:27 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 11/4/2021 7:39:35 AM
PharmaCyte Biotech Announces Encapsulation Material Does Not Alter Cellular DNA Business Wire - 9/27/2021 9:00:00 AM
PharmaCyte Biotech Releases More Positive Results From FDA-Required Biocompatibility Tests Business Wire - 9/21/2021 9:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 9/14/2021 8:02:08 AM
PharmaCyte Biotech to Participate in H.C. Wainwright 23rd Annual Global Investment Conference Business Wire - 9/8/2021 9:00:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/3/2021 7:20:53 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 9/1/2021 6:04:10 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/31/2021 6:25:24 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/31/2021 6:24:54 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/31/2021 6:24:23 PM
PharmaCyte Biotech Establishes 18-Month Shelf Life for Clinical Trial Product in Ongoing Stability Study Business Wire - 8/31/2021 9:20:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 8/30/2021 8:31:26 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 8/30/2021 6:31:47 AM
PharmaCyte Biotech Expands Product Pipeline to Include Diabetes and Malignant Ascites Following $90-Million Capital Raise Business Wire - 8/25/2021 9:00:00 AM
PharmaCyte Biotech Announces Closing of $70 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules Business Wire - 8/23/2021 4:39:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/23/2021 6:09:01 AM
Big movements in Pharmacyt Biotch stock price on Thursday moving 28.36% between high and low StockInvest.us - 8/19/2021 8:10:18 PM
mwebb1514   Tuesday, 09/07/21 03:53:34 PM
Re: A2Z post# 143573
Post # of 144102 
That is a fair argument. I have no knowledge of exactly what was on the list or how long each additional test should take. Waggoner did say it would be done by the end of this year. And he did get big investor buy in after making that statement and moving to Nasdaq. They have the money to move forward. I am in a wait and see holding pattern.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences